Balance Sheet

Assets

+66%

+260%

10Y

Currency: KRW

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	27	356	110	325	525	4 615	1 112	963	1 084	3 978	2 241	4 117	4 539	10 390	9 052	27 579	40 839	54 514	54 234	52 700	20 632	10 644	13 737	10 602
Cash	0	0	0	0	0	0	0	0	0	0	0	4	2	2	0	0	2	1	0	1	1	1	7	7
Cash Equivalents	27	356	110	325	525	4 615	1 112	963	1 084	3 978	2 241	4 113	4 537	10 388	9 052	27 579	40 837	54 513	54 234	52 699	20 631	10 643	13 730	10 595
Short-Term Investments	3	0	0	318	25	5 355	3 086	3 205	3 000	3 138	6 326	3 139	3 080	3 000	5 201	44 447	23 776	16 947	2 285	1 101	20 551	17 503	17 404	25 260
Total Receivables	1 281	1 963	2 995	2 438	3 527	5 107	3 369	1 964	2 652	6 962	6 810	3 101	7 335	3 975	2 556	9 740	8 122	9 244	9 818	5 970	4 327	8 647	8 807	8 713
Accounts Receivables	1 219	1 845	2 895	2 352	3 492	5 106	3 369	1 964	2 652	6 860	6 810	3 101	7 319	3 822	2 556	9 740	7 845	6 699	7 238	3 152	3 747	7 920	7 464	3 922
Other Receivables	62	118	100	86	35	1	0	0	0	102	0	0	16	153	0	0	277	2 545	2 580	2 818	580	727	1 344	4 791
Inventory	4 564	4 051	4 266	5 036	4 201	2 309	5 067	6 331	7 044	5 294	6 280	9 267	7 313	7 941	7 691	7 156	5 647	18 670	8 216	6 982	5 352	7 023	6 247	8 438
Other Current Assets	27	111	36	307	99	53	401	399	417	148	209	175	26	26	86	139	262	16	98	32	83	149	582	94
Total Current Assets	5 902	6 482	7 407	8 423	8 378	17 440	13 036	12 863	14 197	19 521	21 866	19 798	22 294	25 333	24 586	89 061	78 647	99 391	74 651	66 786	50 946	43 966	46 777	53 107
PP&E Net	1 986	1 692	1 503	1 305	1 223	1 142	7 853	7 603	8 050	7 966	7 873	7 660	7 439	7 129	7 798	8 464	9 113	9 051	16 373	16 043	12 662	28 628	27 955	27 227
PP&E Gross	1 986	1 692	1 503	1 305	1 223	1 142	7 853	7 603	8 050	7 966	7 873	7 660	7 439	7 129	0	0	9 113	9 051	16 373	16 043	12 662	28 628	27 955	27 227
Accumulated Depreciation	521	877	1 255	1 651	1 714	2 087	2 134	2 573	2 919	3 235	3 597	3 969	4 309	4 628	0	0	5 133	5 360	5 643	5 996	6 308	14 566	13 217	14 199
Intangible Assets	458	370	227	4	16	403	253	374	308	305	582	479	437	364	290	291	300	200	168	136	123	2 205	1 168	994
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1 656	1 656	1 656
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	80 238	81 191	82 574
Long-Term Investments	0	123	278	23	130	216	231	69	77	77	70	70	0	0	192	459	5 748	4 535	13 047	14 954	73 906	42 099	83 476	65 722
Other Long-Term Assets	52	50	363	59	58	278	285	209	156	211	369	400	424	657	344	258	946	344	931	1 432	1 311	1 466	1 771	1 757
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1 656	1 656	1 656
Total Assets	8 399 N/A	8 716 +4%	9 778 +12%	9 815 +0%	9 806 0%	19 479 +99%	21 658 +11%	21 117 -2%	22 788 +8%	28 079 +23%	30 761 +10%	28 408 -8%	30 594 +8%	33 483 +9%	33 210 -1%	98 534 +197%	94 753 -4%	113 520 +20%	105 170 -7%	99 351 -6%	138 949 +40%	200 257 +44%	243 994 +22%	233 037 -4%
Liabilities
Accounts Payable	2 466	1 909	2 245	1 901	1 588	1 899	1 559	942	1 950	2 210	2 715	2 471	1 847	2 084	1 560	1 818	1 136	3 300	2 908	717	947	4 147	2 882	2 059
Accrued Liabilities	95	227	121	130	132	0	0	0	0	0	0	272	292	284	0	0	103	95	141	119	236	800	556	378
Short-Term Debt	1 421	1 433	2 101	1 301	1 120	139	74	0	0	2 049	2 211	0	0	0	0	0	0	0	0	0	300	1 610	70	8 000
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21	23	25 889	8 055	75 949	8 970
Other Current Liabilities	2 635	2 744	1 862	1 962	758	1 125	1 782	589	514	1 230	1 174	735	1 204	1 072	650	6 533	1 588	14 453	1 337	1 210	15 846	5 091	14 215	3 427
Total Current Liabilities	6 616	6 313	6 329	5 294	3 598	3 163	3 415	1 531	2 465	5 489	6 099	3 478	3 342	3 440	2 210	8 351	2 827	17 848	4 406	2 069	43 218	19 702	93 672	22 833
Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14	18	2 186	65 894	750	64 253
Deferred Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2 046	6 553	4 058
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	81	143	159	246	286	366	391	429	426	609	898	753	800	968	959	292	160	160	591	497	810	4 341	5 006	5 269
Total Liabilities	6 697 N/A	6 456 -4%	6 488 +0%	5 540 -15%	3 884 -30%	3 529 -9%	3 807 +8%	1 960 -49%	2 891 +48%	6 098 +111%	6 997 +15%	4 231 -40%	4 143 -2%	4 407 +6%	3 169 -28%	8 642 +173%	2 988 -65%	18 007 +503%	5 011 -72%	2 583 -48%	46 214 +1 689%	91 983 +99%	105 981 +15%	96 413 -9%
Equity
Common Stock	2 000	2 000	2 000	2 000	2 000	2 900	2 900	2 900	2 900	2 900	2 900	2 900	2 900	2 900	2 900	5 923	5 923	5 923	5 923	5 923	16 610	19 427	23 509	30 427
Retained Earnings	298	260	1 290	2 275	3 921	6 570	9 285	10 889	11 816	14 221	16 745	18 623	21 029	23 654	24 619	41 471	46 582	50 086	54 732	51 341	46 734	43 821	53 083	39 723
Additional Paid In Capital	0	0	0	0	0	6 480	6 480	6 480	6 480	6 480	6 480	6 480	6 480	6 480	6 480	46 494	46 494	46 494	46 494	46 494	35 733	48 045	63 985	68 346
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	647	66	470	1 161
Treasury Stock	0	0	0	0	0	0	814	1 113	1 300	1 620	2 361	3 825	3 958	3 958	0	0	6 990	0	6 990	6 990	6 990	2 952	81	81
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3 958	3 996	244	6 990	0	0	0	0	2 952	2 952
Total Equity	1 702 N/A	2 260 +33%	3 290 +46%	4 275 +30%	5 921 +39%	15 950 +169%	17 851 +12%	19 157 +7%	19 896 +4%	21 980 +10%	23 764 +8%	24 177 +2%	26 452 +9%	29 076 +10%	30 041 +3%	89 892 +199%	91 765 +2%	95 513 +4%	100 159 +5%	96 768 -3%	92 735 -4%	108 274 +17%	138 014 +27%	136 624 -1%
Total Liabilities & Equity	8 399 N/A	8 716 +4%	9 778 +12%	9 815 +0%	9 806 0%	19 479 +99%	21 658 +11%	21 117 -2%	22 788 +8%	28 079 +23%	30 761 +10%	28 408 -8%	30 594 +8%	33 483 +9%	33 210 -1%	98 534 +197%	94 753 -4%	113 520 +20%	105 170 -7%	99 351 -6%	138 949 +40%	200 257 +44%	243 994 +22%	233 037 -4%
Shares Outstanding
Common Shares Outstanding	6	6	6	6	6	9	9	9	9	9	8	8	7	7	7	11	11	11	11	11	6	8	9	12

Income Statement Balance Sheet Cash Flow Statement

NexturnBioScience Co Ltd
KOSDAQ:089140

Balance Sheet

Balance Sheet Decomposition
NexturnBioScience Co Ltd

Balance Sheet
NexturnBioScience Co Ltd

See Also

Company

Help

Tools

Stocks

NexturnBioScience Co Ltd KOSDAQ:089140

Balance Sheet

Balance Sheet Decomposition NexturnBioScience Co Ltd

Balance Sheet NexturnBioScience Co Ltd

See Also

Company

Help

Tools

Stocks

NexturnBioScience Co Ltd
KOSDAQ:089140

Balance Sheet Decomposition
NexturnBioScience Co Ltd

Balance Sheet
NexturnBioScience Co Ltd